S4279 A Rare Case of Herpes Simplex Virus Esophagitis in an Immunocompetent Patient

Introduction: Herpes simplex virus (HSV) rarely causes esophagitis in immunocompetent patients. Here, we present a case of HSV esophagitis in an otherwise healthy 24-year-old man. Case Description/Methods: A 24-year-old man with a past medical history of gastroesophageal reflux disease presented with a 1-week history of nausea, vomiting, odynophagia, epigastric pain, fevers, and a sore throat. He reported significant odynophagia and epigastric abdominal pain with any oral intake including liquids. Upper endoscopy a year prior had shown gastritis for which patient had been taking pantoprazole 20 mg twice daily and famotidine 40 mg daily. Physical exam showed bilateral tonsillar hypertrophy without purulence or erythema. Labs were notable for negative Strep A polymerase chain reaction, negative mononucleosis screen, negative CMV IgM, Westergren RBC sedimentation rate elevated to 61, and negative Helicobacter pylori stool antigen. Subsequent esophagogastroduodenoscopy 4 days after initial presentation revealed severe esophagitis with only small patchy areas of mucosal sparing. Esophageal biopsy was consistent with herpes esophagitis with positive staining for HSV 1/2. He did report a history of cold sores but denied any recent cold sores. He was treated with acyclovir 400 mg 3 times daily for 7 days. A repeat esophagogastroduodenoscopy was recommended in 6-12 months to assess for underlying eosinophilic esophagitis but was never completed as the patient was lost to follow up. Discussion: Although much more commonly seen in immunocompromised patients, herpes esophagitis has been reported in immunocompetent hosts. Literature on herpes esophagitis in immunocompetent individuals is limited however the disease mainly affects young men without other significant comorbidities. The mechanism is not fully understood, however disruption of esophageal mucosal such as secondary to gastroesophageal reflux, eosinophilic esophagitis, or esophageal instrumentation is thought to increase the risk of herpes esophagitis. The disease is usually self-limited, but acyclovir therapy may hasten resolution of symptoms. Although rare, herpes esophagitis should be on the differential for immunocompetent patients presenting with odynophagia, fevers, and retrosternal or epigastric pain.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001144576.66579.01
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4279 A Rare Case of Herpes Simplex Virus Esophagitis in an Immunocompetent Patient

Colin Hartgerink, Joan W. Chen
The American Journal of Gastroenterology
Eosinophilic Esophagitis
article

S4279 A Rare Case of Herpes Simplex Virus Esophagitis in an Immunocompetent Patient

Colin Hartgerink, Joan W. Chen
article en

Abstract

Introduction: Herpes simplex virus (HSV) rarely causes esophagitis in immunocompetent patients. Here, we present a case of HSV esophagitis in an otherwise healthy 24-year-old man. Case Description/Methods: A 24-year-old man with a past medical history of gastroesophageal reflux disease presented with a 1-week history of nausea, vomiting, odynophagia, epigastric pain, fevers, and a sore throat. He reported significant odynophagia and epigastric abdominal pain with any oral intake including liquids. Upper endoscopy a year prior had shown gastritis for which patient had been taking pantoprazole 20 mg twice daily and famotidine 40 mg daily. Physical exam showed bilateral tonsillar hypertrophy without purulence or erythema. Labs were notable for negative Strep A polymerase chain reaction, negative mononucleosis screen, negative CMV IgM, Westergren RBC sedimentation rate elevated to 61, and negative Helicobacter pylori stool antigen. Subsequent esophagogastroduodenoscopy 4 days after initial presentation revealed severe esophagitis with only small patchy areas of mucosal sparing. Esophageal biopsy was consistent with herpes esophagitis with positive staining for HSV 1/2. He did report a history of cold sores but denied any recent cold sores. He was treated with acyclovir 400 mg 3 times daily for 7 days. A repeat esophagogastroduodenoscopy was recommended in 6-12 months to assess for underlying eosinophilic esophagitis but was never completed as the patient was lost to follow up. Discussion: Although much more commonly seen in immunocompromised patients, herpes esophagitis has been reported in immunocompetent hosts. Literature on herpes esophagitis in immunocompetent individuals is limited however the disease mainly affects young men without other significant comorbidities. The mechanism is not fully understood, however disruption of esophageal mucosal such as secondary to gastroesophageal reflux, eosinophilic esophagitis, or esophageal instrumentation is thought to increase the risk of herpes esophagitis. The disease is usually self-limited, but acyclovir therapy may hasten resolution of symptoms. Although rare, herpes esophagitis should be on the differential for immunocompetent patients presenting with odynophagia, fevers, and retrosternal or epigastric pain.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.